Now on
Rare Partners presents a poster on Rapamycin project
Rare Partners announces the presentation of a poster at the ECRD meeting 2012
Rare Partners announces a three parties alliance for thalassemia
Rare Partners announces a three parties alliance for the use of rapamycin in thalassemic patients, based on the research carried out by Professor Roberto Gambari and coworkers at the University of Ferrara.
ll coraggio di andare oltre: a Savona l’ultima sfida di #MiFidoDiTe
ll coraggio di andare oltre: a Savona l’ultima sfida di #MiFidoDiTe
Sirthalaclin clinical trial has started patient enrolment
The clinical trial Sirthalaclin for the treatment of transfusion-dependent beta-thalassemia patients has started patient enrolment.
Rare Partners and Milan Marathon 2015
Rare Partners and Milan Marathon 2015, #runandimagetofly a record edition